1
Return

Sex differences in chemotherapy-induced alopecia distress using the Japanese version of the Chemotherapy-Induced Alopecia Distress Scale

delete2026-08-10
delete0
PRE
AI
H
Hiroki Okumura
S
Shuko Soma
Y
Yosuke Aoyama
Y
Yu Harada
Y
Yoshiko Yonejima
K
Kiyomi Nonogaki
H
Haruka Kono
E
Erisa Toda
H
Haruka Ozaki
M
Masahiro Kuno
S
Shogo Watanabe
K
Kazumasa Yamamoto
K
Kohji Takemura
T
Takeshi Yamaguchi
Y
Yuko Tanabe
A
Atsushi Yokoyama
K
Keita Uchino
K
Koji Hashiguchi
K
Koichi Suyama
Y
Yuji Miura *
DOI:10.1007/s00520-026-11066-2delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
While chemotherapy-induced alopecia (CIA) is a concern for patients with cancer, investigations involving men with CIA are limited. We aimed to examine sex differences in chemotherapy-related distress using the Japanese version of the Chemotherapy-Induced Alopecia Distress Scale (CADS-J). The study, conducted at Toranomon and Yokohama Minami Kyosai Hospitals between March and December 2023, employed a one-time 17-item questionnaire survey (CADS-J) for patients with cancer who had not previously experienced CIA-related hair loss. Each item was scored from 0 (none) to 3 (severe), with total scores ranging from 0 to 51. Of 104 patients who received the questionnaire, 97 were included in the analysis (men, 55 [56.7%]; mean age, 62.6 ± 12.7 years). Metastatic disease was present in 92.7% and 50% of the men and women, respectively. Pancreatic (35%) and gastric (16%) cancers were most common in the men; while pancreatic (26%) and breast (24%) cancers were most common in the women. Common terminology criteria for adverse events (CTCAE) grade 2 CIA was observed in 70.9% and 95.2% of the men and women, respectively. Mean CADS-J total scores were: men, 5.7; women, 13.2 (p < 0.001); women scored significantly higher in every domain. In a multivariable analysis, female sex, wig or hat use, and depressive symptoms (Center for Epidemiologic Studies Depression Scale ≥ 16) were independently associated with higher CADS-J total scores. Among the men, 5/55 (9.1%) had CADS-J total scores ≥ 13 (the female mean); of whom four (80%) had CTCAE grade 2 CIA and wore a wig or hat. To our knowledge, this is the first study to report sex differences in distress associated with CIA using CADS-J. Distress was stronger in women, but some men also experienced marked distress. Further research and clinical evaluations are needed to individualize targeted care.
Keywords:
Chemotherapy-induced alopecia
Sex differences
CADS-J

Journal

Supportive Care in Cancer cover
Supportive Care in Cancer
IF:
3
Papers:
2.0K
Citations:
2.4W

Organization

B
breast oncology center
Scholars:
24
Papers: 15
Citations: 0
D
department of pharmacy
Scholars:
1.2K
Papers: 408
Citations: 0
D
department of medical oncology
Scholars:
2.4K
Papers: 878
Citations: 6
Cited Papers

Cited Papers

Citing Papers

Citing Papers